ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

Overview of attention for article published in Trials, November 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 115 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 23,158 followers.

RT @sue_cotton: Protocol for new trial of NAC for first episode psychosis https://t.co/roC27nbKsv @StephenWood8 @kelly_allott @PatMcGorry @…

Reply Repost Favourite

RT @sue_cotton: Protocol for new trial of NAC for first episode psychosis https://t.co/roC27nbKsv @StephenWood8 @kelly_allott @PatMcGorry @…

Reply Repost Favourite

RT @sue_cotton: Protocol for new trial of NAC for first episode psychosis https://t.co/roC27nbKsv @StephenWood8 @kelly_allott @PatMcGorry @…

Reply Repost Favourite

RT @sue_cotton: Protocol for new trial of NAC for first episode psychosis https://t.co/roC27nbKsv @StephenWood8 @kelly_allott @PatMcGorry @…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.